Patents by Inventor Soon Jang LEE

Soon Jang LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10330672
    Abstract: The present invention relates to a method for screening an activator of mitochondrial activity by using gypenoside-treated cells, to a composition for screening an activator of mitochondrial activity, comprising the gypenoside, and to a kit comprising the composition. By using the method for screening an activator of mitochondrial activity of the present invention, it is possible to effectively discover a preparation which can substantially promote the mitochondrial activity, and thus the method is expected to be widely used in developing a therapeutic agent for diseases caused by mitochondrial activity inhibition.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: June 25, 2019
    Assignee: INTELLIGENT SYNTHETIC BIOLOGY CENTER
    Inventors: Sun Chang Kim, Chan Bae Park, Soon Jang Lee
  • Publication number: 20180228823
    Abstract: The present invention relates to a composition for preventing, improving, or treating diabetes mellitus, and more specifically, relates to pharmaceutical, food, and feed compositions comprising gypenoside 75 or a pharmaceutically acceptable salt thereof. Additionally, the present invention relates to a method for preventing or treating diabetes mellitus using the composition.
    Type: Application
    Filed: May 4, 2016
    Publication date: August 16, 2018
    Inventors: Sun Chang KIM, Chan Bae PARK, Soon Jang LEE
  • Publication number: 20170292945
    Abstract: The present invention relates to a method for screening an activator of mitochondrial activity by using gypenoside-treated cells, to a composition for screening an activator of mitochondrial activity, comprising the gypenoside, and to a kit comprising the composition. By using the method for screening an activator of mitochondrial activity of the present invention, it is possible to effectively discover a preparation which can substantially promote the mitochondrial activity, and thus the method is expected to be widely used in developing a therapeutic agent for diseases caused by mitochondrial activity inhibition.
    Type: Application
    Filed: June 22, 2016
    Publication date: October 12, 2017
    Inventors: Sun Chang KIM, Chan Bae PARK, Soon Jang LEE